Drug production activity extremely low due to IMF economic woes.

Published: 1999-03-04 17:35:00

Updated: 1999-03-04 17:35:00

According to the KPMA statistics, the pharmaceutical production recorded an unprecedented negative growth figure in 1998 by 3% decreased from 8.6% growth of the previous year, almost 10% points drop, reflecting serious economic hardship after the IMF turmoil and a protracted drug market recession...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK